I have returned to China, and in the past two days, I have compiled the knowledge I learned at Massachusetts General Hospital about surgical treatment of spinal tumors, and I am also ready to summarize and reflect on my experience in surgical treatment of spinal tumors over the years, so that I can make comparisons and promote the development of spinal tumor surgery. The treatment of spinal tumors has always been a difficult problem in spine surgery, as 80% of spinal tumor patients are metastatic cancer, which greatly affects the efficacy of treatment and greatly discourages physicians and patients in the treatment. Massachusetts General Hospital has a dedicated group of physicians for spine tumors, as well as very close ties with pathology, general surgery, medical oncology, radiation therapy, interventional medicine, etc. Any tumor patient is decided by all the doctors involved, thus ensuring the best treatment for the patient. In spine surgery, the basic viewpoint and surgical approach are the same as ours, but because the American physician’s philosophy of treatment is based on reducing recurrence rates, preserving the patient’s life, and maximizing financial security, as well as patient compliance, the scope of surgery is often much greater than ours. This also means much greater trauma to the patient, much greater possible loss or impairment of body functions, much greater time and need for rehabilitation, and of course a much greater economic burden. How to find a reasonable balance on this point requires more research. One of the outstanding aspects of tumor treatment at Massachusetts General Hospital is its equipment and experience in intraoperative radiotherapy, which is certainly something we are currently lacking. I feel most strongly that the treatment of spinal tumors remains difficult.